Hany Massarany's most recent trade in Biodesix Inc was a trade of 26,368 Common Stock done . Disclosure was reported to the exchange on July 1, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Biodesix Inc | Hany Massarany | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2025 | 26,368 | 310,135 | - | - | Common Stock | |
| Biodesix Inc | Hany Massarany | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2025 | 26,368 | 0 | - | - | Restricted Stock Units | |
| Biodesix Inc | Hany Massarany | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2025 | 86,477 | 86,477 | - | - | Restricted Stock Units | |
| Biodesix Inc | Hany Massarany | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2025 | 42,010 | 42,010 | - | - | Stock Options (Right to Buy) | |
| Biodesix Inc | Hany Massarany | Director | Purchase of securities on an exchange or from another person at price $ 1.37 per share. | 05 Nov 2024 | 22,500 | 53,364 | - | 1.4 | 30,866 | Common Stock |
| Accelerate Diagnostics Inc | Hany Massarany | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Jun 2024 | 4,737 | 36,891 (0%) | 0% | 0 | Common Stock | |
| Accelerate Diagnostics Inc | Hany Massarany | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Jun 2024 | 4,737 | 18,947 | - | - | Restricted Stock Units | |
| Accelerate Diagnostics Inc | Hany Massarany | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 May 2024 | 7,894 | 32,154 (0%) | 0% | 0 | Common Stock | |
| Accelerate Diagnostics Inc | Hany Massarany | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 May 2024 | 7,894 | 0 | - | - | Restricted Stock Units | |
| Biodesix Inc | Hany Massarany | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 57,246 | 57,246 | - | - | Restricted Stock Units | |
| Biodesix Inc | Hany Massarany | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 37,050 | 37,050 | - | - | Stock Options (Right to Buy) | |
| Accelerate Diagnostics Inc | Hany Massarany | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2024 | 66,667 | 66,667 | - | - | Restricted Stock Units | |
| Accelerate Diagnostics Inc | Massarany Hany | Director | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 23 Jan 2024 | 16,666 | 16,666 | - | - | Common Stock Warrants (right to buy) | |
| Accelerate Diagnostics Inc | Massarany Hany | Director | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 23 Jan 2024 | 16,666 | 24,260 (0%) | 0% | - | Common Stock | |
| Biodesix Inc | Hany Massarany | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2024 | 105,389 | 142,924 | - | - | Restricted Stock Units | |
| Biodesix Inc | Hany Massarany | Director | Grant, award, or other acquisition of securities at price $ 1.62 per share. | 03 Aug 2023 | 30,864 | 30,864 | - | 1.6 | 50,000 | Common Stock |
| Accelerate Diagnostics Inc | Hany Massarany | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jun 2023 | 236,842 | 236,842 | - | - | Employee Restricted Stock Units | |
| Accelerate Diagnostics Inc | Hany Massarany | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 May 2023 | 75,949 | 75,949 (0%) | 0% | 0 | Common Stock | |
| Accelerate Diagnostics Inc | Hany Massarany | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 May 2023 | 75,949 | 0 | - | - | Employee Restricted Stock Units | |
| Accelerate Diagnostics Inc | Hany Massarany | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2023 | 78,947 | 78,947 | - | - | Employee Restricted Stock Units | |
| Biodesix Inc | Hany Massarany | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2023 | 37,535 | 37,535 | - | - | Restricted Stock Units | |
| Biodesix Inc | Hany Massarany | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Mar 2023 | 145,833 | 283,767 | - | - | Common Stock | |
| Biodesix Inc | Hany Massarany | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Mar 2023 | 145,833 | 6,707 | - | - | Restricted Stock Units | |
| Biodesix Inc | Hany Massarany | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 6,707 | 152,540 | - | - | Restricted Stock Units | |
| Biodesix Inc | Hany Massarany | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2023 | 62,500 | 145,833 | - | - | Restricted Stock Units | |
| Biodesix Inc | Hany Massarany | Director | Purchase of securities on an exchange or from another person at price $ 1.15 per share. | 21 Nov 2022 | 130,434 | 137,934 | - | 1.1 | 149,999 | Common Stock |
| Accelerate Diagnostics Inc | Hany Massarany | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2022 | 75,949 | 75,949 | - | - | Employee Restricted Stock Units | |
| Biodesix Inc | Hany Massarany | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 May 2022 | 83,333 | 83,333 | - | - | Restricted Stock Units | |
| Accelerate Diagnostics Inc | Hany Massarany | Director | Purchase of securities on an exchange or from another person at price $ 3.30 per share. | 31 Jan 2022 | 20,000 | 30,000 (0%) | 0% | 3.3 | 66,000 | Common Stock |
| Accelerate Diagnostics Inc | Hany Massarany | Director | Purchase of securities on an exchange or from another person at price $ 5.30 per share. | 27 Sep 2021 | 10,000 | 10,000 (0%) | 0% | 5.3 | 53,000 | Common Stock |
| Biodesix Inc | Hany Massarany | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jun 2021 | 25,789 | 25,789 | - | - | Stock Options (Right to buy) | |
| Accelerate Diagnostics Inc | Hany Massarany | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2021 | 93,783 | 93,783 | - | - | Stock Option (right to buy) | |
| Accelerate Diagnostics Inc | Hany Massarany | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2021 | 31,261 | 31,261 | - | - | Stock Option (right to buy) |